University of Missouri, Kansas City — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications3liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Intervention to Reduce Perceived Cognitive Impairment in Multiple SclerosisMultiple sclerosis (MS) is among the most prevalent autoimmune diseases among young and middle-aged adults. Up to 65% of MS patients experience objective cognitive impairment including problems with information processing speed, memory, and executive functioning. However, patients commonly overestimate the extent of their cognitive dysfunction which can result in inaccurate perceptions of their true cognitive abilities. Exaggerated perceptions of cognitive impairment are predictive of future decline and associated with depression, anxiety, and reduced quality of life. Despite this, no study has examined an intervention aimed at changing misperceptions related to perceived cognitive impairment in MS when objective measures are incongruent with self-reported cognitive symptoms. The purpose of the present study is to develop and pilot a brief intervention for MS patients who perceive cognitive impairment, but perform in the normal or expected range on objective measures of cognition.	SEP	NA	Traitement symptomatique	United States	À vérifier
Intervention to Reduce Perceived Cognitive Impairment in Multiple SclerosisMultiple sclerosis (MS) is among the most prevalent autoimmune diseases among young and middle-aged adults. Up to 65% of MS patients experience objective cognitive impairment including problems with information processing speed, memory, and executive functioning. However, patients commonly overestimate the extent of their cognitive dysfunction which can result in inaccurate perceptions of their true cognitive abilities. Exaggerated perceptions of cognitive impairment are predictive of future decline and associated with depression, anxiety, and reduced quality of life. Despite this, no study has examined an intervention aimed at changing misperceptions related to perceived cognitive impairment in MS when objective measures are incongruent with self-reported cognitive symptoms. The purpose of the present study is to develop and pilot a brief intervention for MS patients who perceive cognitive impairment, but perform in the normal or expected range on objective measures of cognition.	SEP	NA	Traitement symptomatique	United States	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
Intervention to Reduce Perceived Cognitive Impairment in Multiple Sclerosis	SEP	NA	NCT03889327	Intervention to Reduce Perceived Cognitive Impairment in Multiple Sclerosis	COMPLETED

Publications

3

Molécule	Indication / population	Titre	Journal	Date
Intervention to Reduce Perceived Cognitive Impairment in Multiple Sclerosis		Social participation and self-reported physical, cognitive, and fall-related outcomes in persons with multiple sclerosis.	Multiple sclerosis and related disorders
Intervention to Reduce Perceived Cognitive Impairment in Multiple Sclerosis		Complex emotion recognition in neurological and neurodevelopmental conditions.	Acta psychologica
Intervention to Reduce Perceived Cognitive Impairment in Multiple Sclerosis		A Qualitative Study of Lived Treatment Experiences and Preferences of Long-Term DMT Users with Relapsing-Remitting Multiple Sclerosis.	Neurology and therapy